Biomedical Research & Development Services
Healthcare research has never been more important. Time and time again, our biomedical research and development (R&D) has resulted in products that have advanced the understanding of disease and transformed the practice of medicine. This has always been the lifeblood of our company, and our substantial investment in R&D reflects that.
Details
Having Diagnostics and Pharmaceuticals in one company is a powerful advantage that sets Roche apart. Close cooperation between the two is central to our personalised healthcare strategy. Although they have different R&D processes, the two divisions share expertise, research facilities and technologies when working together on projects.
At the same time, we believe that diversity in scientific thinking will produce the innovations in healthcare so desperately needed by society. That’s why we maintain three, independently-operated Pharma R&D units, alongside a strong network of more than 150 external partner organisations.
Pharma Research and Early Development (pRED), Genentech Research and Early Development (gRED), and Chugai in Japan provide this diversity of scientific approach, as well as enabling access to expertise, new technologies and promising drug candidates.
Customer reviews
No reviews were found for Biomedical Research & Development Services. Be the first to review!